Posted by Michael Wonder on 12 Oct 2016
CADTH calls for patient input on submission from Servier for Corlovan
11 October - CADTH is calling for patient input on a submission from Servier for Corlovan (ivabradine hydrochloride).
Servier is seeking a favourable outcome from CADTH on the use of ivabradine hydrochloride by patients with NYHA class II to IV heart failure.
The submission is due on 8 November 2016.
